DXCM

Dexcom

$58.42

-1.75 (-2.91%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$84.96
(+45.43%)
Strong Buy: 4
Buy: 20
Hold: 4
Sell: 0
Strong Sell: 0
Description:
DexCom, Inc. is a prominent leader in diabetes care, renowned for its groundbreaking continuous glucose monitoring (CGM) systems that empower patients to manage their diabetes effectively. Headquartered in San Diego, California, with a strategic manufacturing facility in Mesa, Arizona, the company is dedicated to advancing diabetes management through innovative technology and exceptional product quality. As a pioneer in glucose monitoring, DexCom is actively expanding its global presence to meet the rising demand for effective diabetes solutions, positioning itself as a key player in the evolving healthcare landscape.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL DEVICES
Address:
6340 SEQUENCE DRIVE, SAN DIEGO, CA, UNITED STATES, 92121
Fiscal year end:
December
Market capitalization:
$23.6 Billion
EBITDA:
$1.02 Billion
PERatio:
33.43
EPS:
1.8
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.524

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+180%
How much will you get:
$2,795
Prices dates:
30-10-2015: $20.83 and 31-10-2025: $58.22